2017 Keynote Speakers
Patrick H. Conway, MD, MSc
Patrick Conway, MD, MSc, is the CMS Acting Principal Deputy Administrator and Deputy Administrator for Innovation and Quality & CMS Chief Medical Officer. As the CMS Acting Principal Deputy Administrator and CMS Chief Medical Officer, Dr. Conway is responsible for overseeing the programs that serve the over 130 million Americans that access health care services through Medicare, Medicaid, the Children’s Health Insurance Program, and the Health Insurance Marketplace. He and the CMS team focus on health system transformation by improving quality, health outcomes, access and affordability, combatting health care fraud and reducing health disparities. He is a national and international leader in health system transformation and improvement.
As the Deputy Administrator for Innovation and Quality, Dr. Conway leads the Center for Medicare and Medicaid Innovation (CMMI) at CMS. The CMS Innovation Center is responsible for testing numerous new payment and service delivery models across the nation. Models include accountable care organizations, bundled payments, primary care medical homes, state innovation models, and many more. Successful models can be scaled nationally. The CMS Innovation Center budget is $10 billion over 10 years.
Previously, he was Director of Hospital Medicine and an Associate Professor at Cincinnati Children's Hospital. He was also AVP Outcomes Performance, responsible for leading measurement, including the electronic health record measures, and facilitating improvement of health outcomes across the health care system. Other relevant experience includes previous work as the Chief Medical Officer at the Department of Health and Human Services (HHS) in the Office of the Assistant Secretary for Planning and Evaluation. In 2007-08, he was a White House Fellow assigned to the Office of Secretary in HHS and the Director of the Agency for Healthcare Research and Quality. He also served as Executive Director of the Federal Coordinating Council on Comparative Effectiveness Research coordinating the investment of the $1.1 billion for CER in the Recovery Act. He was a Robert Wood Johnson Clinical Scholar and completed a Master's of Science focused on health services research and clinical epidemiology at the University of Pennsylvania and Children's Hospital of Philadelphia. Previously, he was a management consultant at McKinsey & Company, serving senior management of mainly health care clients on strategy projects.
In 2014, he was elected to the Institute of Medicine (IOM) recognizing individuals who have demonstrated outstanding professional achievement. Election to the IOM is considered one of the highest honors in the fields of health and medicine. He has published articles in journals such as JAMA, New England Journal of Medicine, Health Affairs, and Pediatrics and given national presentations on topics including health care policy, quality of care, comparative effectiveness, hospitalist systems, and quality improvement. He is a practicing pediatric hospitalist and was selected as a Master of Hospital Medicine from the Society of Hospital Medicine. He has received the President’s Distinguished Senior Executive Rank and HHS Secretary’s Distinguished Service awards. These are the President’s and Secretary’s highest distinction for executive excellence. He completed pediatrics residency at Harvard Medical School's Children's Hospital Boston, graduated with High Honors from Baylor College of Medicine, and graduated summa cum laude from Texas A&M University.
Ms. Daphne Zohar is the founder and Chief Executive Officer of PureTech Health (PRTC.L) and a member of the Board. PureTech Health is a modern biopharmaceutical company with a robust pipeline of clinical and pivotal stage product candidates that target major chronic diseases. PureTech Health is focused on the adaptive systems of the human body which serve as the body’s primary interface with the environment, a major driver of chronic disease. The adaptive human systems include the immune system, the central nervous system and the enteric nervous system in the gut. Zohar created PureTech Health, assembling a leading team to help implement her vision for the Company, and attracting several hundred million dollars to the Company and its platforms. Zohar has been recognized as a top leader and innovator in biotechnology by a number of sources, including EY, BioWorld, MIT's Technology Review, the Boston Globe, and Scientific American. She sits on the Technology Development Fund Advisory Board at Children's Hospital Boston and is an Editorial Advisor to Xconomy, a national news company. Twitter: @daphnezohar